Recbio
Recbio(HKEX:02179) is an innovative vaccine company founded in 2012. With the vision of "Become the Leader of Innovative Vaccine in the Future," Recbio takes "Protect Human Health with Best-in-Class Vaccines" as its mission. It has established three major cutting-edge technology platforms including novel adjuvants platform, protein engineering platform, and immunological evaluation platform. Recbio has a high-value vaccine portfolio consisted of recombinant protein, HPV vaccine candidates, COVID-19 vaccine candidates, shingles vaccine candidates, influenza vaccine candidates, adults TB vaccine candidates, etc. The core scientific team has more than 20 years of experience in the development and commercialization of innovative vaccines. For more information, please visit
7-day free trial · no credit card
Verified contacts
12
available on Kipplo
LinkedIn employees
22
201 to 500 range
Open roles
—
no listings
Distinct roles
9
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 12 verified contacts at Recbio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
12 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Recbio
9 distinct titles indexed · top 9 shown.
- 2维修主管
- 1a public company
- 1executive dirctor, clinical opeartions
- 1gm's secretary
- 1hrbp
- 1manager of investor relations
- 1公关主管
- 1药物警戒总监
- 1首席财务官
Sign up to unlock all 12 contacts at Recbio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 12 verified contacts at Recbio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.